Page 3 - Les meilleurs doctors traitant la maladie suivante : Thymome - TOP -57 des médecins

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Le Dr Shruti Kate est spécialisée dans les traitements avancés contre le cancer, notamment l'immunothérapie et la thérapie métronomique pour le thymome. Elle a été formée au Tata Memorial Hospital, un leader en oncologie.

• Être experte en cancers du poumon, du sein et génito-urinaires
• Être membre de l'ASCO, de l'ESMO et d'autres sociétés oncologiques de premier plan
• Présenter des recherches lors de la Conférence mondiale sur le cancer du poumon
• Se concentrer sur des traitements innovants comme l'immunothérapie

Le Dr Mehmet Ozek est un neurochirurgien hautement respecté avec plus de 23 ans d'expérience, spécialisé dans les procédures neurochirurgicales complexes.

• Se spécialiser dans la chirurgie endoscopique de la base du crâne et la neurochirurgie fonctionnelle
• Recevoir de multiples prix prestigieux, dont le prix de la recherche scientifique Prof. Dr Mahir Tevruz 2013
• Publier 47 articles dans des revues internationales SCI et présenter des communications lors de 33 réunions scientifiques internationales
• Être membre de l'AANS (American Association of Neurological Surgeons) et d'autres sociétés neurochirurgicales de premier plan

Le Dr Sridhar P.S. se spécialise dans la radiothérapie du thymome au HCG Manavata Cancer Centre, avec une formation approfondie en radio-oncologie.

• Certifié en radiothérapie avec plus de 20 ans d'expérience
• Membre de l'Association of Radiation Oncology of India
• Formé à la Banaras Hindu University et au National Board of Examination
• Actif au sein de la Society for Neuro-Oncology et du Bangalore Oncology Group

Le Dr Borde a réalisé plus de 30 000 TEP et traité plus de 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Spécialisation dans les thérapies à l'iode radioactif et au Lu-177 RN
• Maîtrise des examens TEP-TDM et de la cardiologie nucléaire
• Chercheur publié dans des revues médicales

Plus de 50 000 chirurgies oncologiques en 19 ans – Le Dr Nagarkar se concentre sur l'amélioration de la qualité de vie grâce à l'oncologie chirurgicale de précision.

• Formé au Tata Memorial Hospital et au Royal College of Surgeons d'Édimbourg
• Spécialisé en oncologie chirurgicale mammaire et thoracique
• Impliqué dans plus de 200 essais cliniques (phases 1 à 3)
• Professeur pour le DNB Superspecialty en oncologie chirurgicale et chirurgie mammaire

Le professeur associé Emrah Eraslan est spécialisé en oncologie, avec un accent particulier sur le cancer du poumon, incluant les cas de thymome.

• Spécialiste en médecine interne et oncologie médicale avec plus de 12 ans d'expérience
• Formé et en poste dans les plus grandes institutions d'oncologie en Turquie
• Auteur de multiples articles contribuant à la recherche en oncologie